AZ

Arie Zask

Pfizer: 20 patents #159 of 5,153Top 4%
AC American Cyanamid: 8 patents #178 of 1,554Top 15%
AP Amerimas Home Products: 4 patents #174 of 715Top 25%
SC Shandong Luoxin Pharmaceutical Group Stock Co.: 1 patents #13 of 29Top 45%
CU Columbia University: 1 patents #1,151 of 2,492Top 50%
Overall (All Time): #95,842 of 4,157,543Top 3%
35
Patents All Time

Issued Patents All Time

Showing 25 most recent of 35 patents

Patent #TitleCo-InventorsDate
12377107 NT5C2 inhibitors for the treatment of chemotherapy-resistant acute lymphoblastic leukemia Chelsea Dieck, Adolfo A. Ferrando, Brent R. Stockwell 2025-08-05
12227500 Substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum stress Brent R. Stockwell, Hynek Wichterle, Pieter Harm BOS, Sebastian Thams, Emily Rhodes Lowry 2025-02-18
10022381 Triazine compounds as PI3 kinase and mTOR inhibitors Aranapakam Mudumbai Venkatesan, Zecheng Chen, Christoph Martin Dehnhardt, Osvaldo Dos Santos, Efren Guillermo Delos Santos +8 more 2018-07-17
9796732 Pyridopyrimidine or pyrimidopyrimidine compound, prepration method, pharmaceutical composition, and use thereof Jingkang Shen, Ke Yu, Tao Meng, Lanping Ma, Lanfang Meng +2 more 2017-10-24
9174963 Triazine compounds as PI3 kinase and MTOR inhibitors Aranapakam Mudumbai Venkatesan, Zecheng Chen, Christoph Martin Dehnhardt, Osvaldo Dos Santos, Efren Guillermo Delos Santos +8 more 2015-11-03
8859542 Triazine compounds as PI3 kinase and mTOR inhibitors Aranapakam Mudumbai Venkatesan, Zecheng Chen, Christoph Martin Dehnhardt, Osvaldo Dos Santos, Efren Guillermo Delos Santos +8 more 2014-10-14
8835429 Pyrimidine compounds, their use as mTOR kinase and Pl3 kinase inhibitors, and their syntheses Kevin Joseph Curran, Joshua A. Kaplan, David Richard, Jeroen Cunera Verheijen 2014-09-16
8748421 Triazine compounds as P13 kinase and MTOR inhibitors Aranapakam Mudumbai Venkatesan, Zecheng Chen, Christoph Martin Dehnhardt, Osvaldo Dos Santos, Efren Guillermo Delos Santos +8 more 2014-06-10
8575159 Triazine compounds as PI3 kinase and mTOR inhibitors Aranapakam Mudumbai Venkatesan, Zecheng Chen, Christoph Martin Dehnhardt, Osvaldo Dos Santos, Efren Guillermo Delos Santos +8 more 2013-11-05
8445486 Triazine compounds as PI3 kinase and mTOR inhibitors Aranapakam Mudumbai Venkatesan, Zecheng Chen, Christoph Martin Dehnhardt, Osvaldo Dos Santos, Efren Guillermo Delos Santos +8 more 2013-05-21
8217036 Triazine compounds as PI3 kinase and mTOR inhibitors Aranapakam Mudumbai Venkatesan, Zecheng Chen, Christoph Martin Dehnhardt, Osvaldo Dos Santos, Efren Guillermo Delos Santos +8 more 2012-07-10
8129371 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors Joshua A. Kaplan, Jeroen Cunera Verheijen, Kevin Joseph Curran, David Richard, Semiramis Ayral-Kaloustian 2012-03-06
8039469 Triazine compounds as PI3 kinase and mTOR inhibitors Aranapakam Mudumbai Venkatesan, Zecheng Chen, Christoph Martin Dehnhardt, Osvaldo Dos Santos, Efren Guillermo Delos Santos +8 more 2011-10-18
7713994 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof Hwei-Ru Tsou, Semiramis Ayral-Kaloustian, Gary Harold Birnberg, Middleton B. Floyd, Jr., Joshua A. Kaplan +9 more 2010-05-11
7666901 Analogs of 17-hydroxywortmannin as PI3K inhibitors Ping Cai, Jianxin Gu, Joshua A. Kaplan, Ker Yu, Tianmin Zhu 2010-02-23
7626023 Compounds for treating tumors Joshua A. Kaplan, Ayako Yamashita, Chuan S. Niu, Gary Harold Birnberg, Emily Norton +5 more 2009-12-01
7470794 Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors Frances C. Nelson, James M. Chen, Dominick Mobilio, Ramaswamy Nilakantan 2008-12-30
7390910 Compounds for treating tumors Joshua A. Kaplan, Ayako Yamashita, Chuan S. Niu, Gary Harold Birnberg, Emily Norton +5 more 2008-06-24
6946473 Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors Jeremy Levin, James M. Chen, Xue-Mei Du, Jay D. Albright 2005-09-20
6825352 Preparation and use of ortho-sulfonamido arylhydroxamic acids as matrix metalloproteinase inhibitors Frances C. Nelson, James M. Chen, Dominick Mobilio, Ramaswamy Nilakantan 2004-11-30
6753337 Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors Jeremy Levin, Aranapakam Mudumbai Venkatesan, James M. Chen, Vincent P. Sandanayaka, Mila T. Du +1 more 2004-06-22
6548524 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors Jeremy Levin, Yansong Gu, Jay D. Albright, Xuemei Du 2003-04-15
6534491 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors Jeremy Levin, Yansong Gu, Jay D. Albright, Xuemei Du 2003-03-18
6498167 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors Jeremy Levin, Yansong Gu, Jay D. Albright, Xuemei Du 2002-12-24
6465508 Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors Frances C. Nelson, James M. Chen, Dominick Mobilio, Ramaswamy Nilakantan 2002-10-15